Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Biotechnology companies of the United Kingdom (31 P) Biotechnology companies of the United States (6 C, 331 P) Pages in category "Biotechnology companies by country"
List of countries by stem cell research trials; B. ... National Biotechnology Development Agency This page was last edited on 5 January 2023, at 15:50 (UTC). ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Companies portal; Biology portal; Technology portal; Biotechnology companies are those that manufacture products utilizing biotechnology.Many pharmaceutical companies can be nominally classified in this category based not on the use of biotechnology during the drug discovery process, but on having one or more marketed products that is manufactured utilizing biotechnology.
Rank Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469
Among continents, European countries sold the highest dollar value worth of exported drugs and medicines during 2018 with shipments from Europe totaling $295.8 billion or 79.70% of the global total. In second place were Asian pharmaceutical exporters at 10.70% while 8.10% of worldwide drugs and medicine shipments originated from North America.
In May 2006 AstraZeneca agreed to buy Cambridge Antibody Technology, then the largest UK-based biotechnology company, for £702 million. [25] [26] In April 2007 AstraZeneca agreed to acquire the U.S.-based biotechnology company MedImmune for $15.6 billion. [27]